165 related articles for article (PubMed ID: 9402687)
1. Single dose anti-CD4 monoclonal antibody for induction of tolerance to cardiac allograft in high- and low-responder rat strain combinations.
Qi Z; Riesbeck K; Ostraat O; Tufveson G; Ekberg H
Transpl Immunol; 1997 Sep; 5(3):204-11. PubMed ID: 9402687
[TBL] [Abstract][Full Text] [Related]
2. Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB 5/2) or depleting (OX-38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen.
Arima T; Lehmann M; Flye MW
Transplantation; 1997 Jan; 63(2):284-92. PubMed ID: 9020332
[TBL] [Abstract][Full Text] [Related]
3. Cellular basis of allograft rejection in vivo. V. Examination of the mechanisms responsible for the differing efficacy of monoclonal antibody to CD4+ T cell subsets in low- and high-responder rat strains.
Ilano AL; McConnell MV; Gurley KE; Spinelli A; Pearce NW; Hall BM
J Immunol; 1989 Nov; 143(9):2828-36. PubMed ID: 2572644
[TBL] [Abstract][Full Text] [Related]
4. Induction of donor-specific unresponsiveness to cardiac allografts in rats by pretransplant anti-CD4 monoclonal antibody therapy.
Shizuru JA; Seydel KB; Flavin TF; Wu AP; Kong CC; Hoyt EG; Fujimoto N; Billingham ME; Starnes VA; Fathman CG
Transplantation; 1990 Sep; 50(3):366-73. PubMed ID: 1976282
[TBL] [Abstract][Full Text] [Related]
5. Specific B cell tolerance is induced by cyclosporin A plus donor-specific blood transfusion pretreatment: prolonged survival of MHC class I disparate cardiac allografts.
Yang CP; Shittu E; Bell EB
J Immunol; 2000 Mar; 164(5):2427-32. PubMed ID: 10679079
[TBL] [Abstract][Full Text] [Related]
6. Contributions of donor and host blood vessels in CNS allografts.
Baker-Cairns BJ; Sloan DJ; Broadwell RD; Puklavec M; Charlton HM
Exp Neurol; 1996 Nov; 142(1):36-46. PubMed ID: 8912897
[TBL] [Abstract][Full Text] [Related]
7. Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. III. Further characterization of the CD4+ suppressor cell and its mechanisms of action.
Hall BM; Pearce NW; Gurley KE; Dorsch SE
J Exp Med; 1990 Jan; 171(1):141-57. PubMed ID: 2136906
[TBL] [Abstract][Full Text] [Related]
8. Tolerance or rejection: A delicate balance as judged by exposure of heart-transplanted rats to the immunomodulator Linomide.
Qi Z; Tufveson G; Ekberg H
Scand J Immunol; 1999 Oct; 50(4):394-8. PubMed ID: 10520179
[TBL] [Abstract][Full Text] [Related]
9. Tolerance to heart and kidney grafts induced by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) versus depleting anti-CD4 monoclonal antibody (OX-38) with donor antigen administration.
Motoyama K; Arima T; Lehmann M; Flye MW
Surgery; 1997 Aug; 122(2):213-9; discussion 219-20. PubMed ID: 9288125
[TBL] [Abstract][Full Text] [Related]
10. CTLA4-Ig abrogates the anti-globulin response and prolongs cardiac allograft survival after anti-CD2 treatment.
Stell D; Marshall H; Bradley JA; Bolton EM
Transpl Immunol; 2003; 12(1):1-7. PubMed ID: 14551027
[TBL] [Abstract][Full Text] [Related]
11. Role of double-negative regulatory T cells in long-term cardiac xenograft survival.
Chen W; Ford MS; Young KJ; Cybulsky MI; Zhang L
J Immunol; 2003 Feb; 170(4):1846-53. PubMed ID: 12574350
[TBL] [Abstract][Full Text] [Related]
12. The role of CD8 and CD4 T cells in intestinal allograft rejection: a comparison of monoclonal antibody-treated and knockout mice.
He G; Hart J; Kim OS; Szot GL; Siegel CT; Thistlethwaite JR; Newell KA
Transplantation; 1999 Jan; 67(1):131-7. PubMed ID: 9921809
[TBL] [Abstract][Full Text] [Related]
13. Induction of "infectious" tolerance to MHC-incompatible cardiac allografts in CD4 monoclonal antibody-treated sensitized rat recipients.
Onodera K; Lehmann M; Akalin E; Volk HD; Sayegh MH; Kupiec-Weglinski JW
J Immunol; 1996 Sep; 157(5):1944-50. PubMed ID: 8757313
[TBL] [Abstract][Full Text] [Related]
14. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide.
Chowdhury NC; Saborio DV; Garrovillo M; Chandraker A; Magee CC; Waaga AM; Sayegh MH; Jin MX; Oluwole SF
Transplantation; 1998 Oct; 66(8):1059-66. PubMed ID: 9808492
[TBL] [Abstract][Full Text] [Related]
15. A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection.
Yuan X; Dong VM; Coito AJ; Waaga AM; Salama AD; Benjamin CD; Sayegh MH; Chandraker A
Transplantation; 2002 Jun; 73(11):1736-42. PubMed ID: 12084995
[TBL] [Abstract][Full Text] [Related]
16. The effects of leflunomide and cyclosporin A on rejection of cardiac allografts in the rat.
Ostraat O; Qi ZQ; Tufveson G; Hedlund G; Ekberg H
Scand J Immunol; 1998 Mar; 47(3):236-42. PubMed ID: 9519862
[TBL] [Abstract][Full Text] [Related]
17. Lymphocyte changes associated with prolongation of cardiac allograft survival in adult mice using anti-CD4 monoclonal antibody.
Pearson TC; Bushell AR; Darby CR; West LJ; Morris PJ; Wood KJ
Clin Exp Immunol; 1993 May; 92(2):211-7. PubMed ID: 8097975
[TBL] [Abstract][Full Text] [Related]
18. Combined FTY720/cyclosporine A treatment promotes graft survival and lowers the peripheral lymphocyte count in DA to lewis heart and skin transplantation models.
Nikolova Z; Hof A; Baumlin Y; Hof RP
Transpl Immunol; 2001 Feb; 8(4):267-77. PubMed ID: 11316070
[TBL] [Abstract][Full Text] [Related]
19. Administration of anti-CD4 monoclonal antibody with intrathymic injection of alloantigen results in rat cardiac allograft tolerance.
Arima T; Goss JA; Walp LA; Flye MW
Surgery; 1995 Aug; 118(2):265-72; discussion 272-3. PubMed ID: 7638743
[TBL] [Abstract][Full Text] [Related]
20. Antithymocyte globulin and cyclosporin A are synergistic in an experimental transplantation tolerance model in the rat.
Olausson M; Lukes D; Norrby J; Qi Z; Ekberg H; Gannedahl G; Tufveson G; Mjörnstedt L
Scand J Immunol; 1999 Jan; 49(1):38-44. PubMed ID: 10023855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
